Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   The US Study for Evaluating Endovascular Treatments of Lesions in the Superficial Femoral Artery & Proximal Popliteal by Using the Protege Everflex Nitinol Stent System II (DURABILITY II)
Description of Research   The purpose of this study is to determine if the Ever Flex stent is more safe and effective than percutaneous transluminal angioplasty (PTA) when used in subjects with atherosclerotic narrowing of the arteries in the leg above the knee.
Study Number   HSR-09-1003
Inclusion/Notes   The study is designed to treat patients who may have been treated previously with a balloon angioplasty (PTA) and are experiencing recurrence of the narrowing, or those who have not been treated previously. Patients who require a procedure to improve the blood flow to their legs based on results of their standard pre-testing exams that determine severity of disease will be considered for the study.
Principal Investigator   Herbert Aronow, MD
Contact Name   Cheryl Marentette, RN
Phone   (734) 712-8000
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456